Yutaka Hashimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yutaka Hashimoto has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Ileana Mihaela Cristea
Princeton University
2 shared publications Arthur P. Arnold
University of California, Los Angeles (UCLA) - Department of Integrative Biology & Physiology
1 shared publication- Atsushi Okada
Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
1 shared publication Frank Conlon
University of North Carolina (UNC) at Chapel Hill - Department of Biology and Genetics
1 shared publication- Haley A. Davies
Department of Biology and Genetics, McAllister Heart Institute (W.S., A.P.S., J.I.E., H.A.D., F.L.C.), the University of North Carolina at Chapel Hill
1 shared publication - Joel D. Federspiel
Drug Safety Research & Development, Pfizer, Inc, Andover, Massachusetts, USA
1 shared publication
Latest Publications
- Open Access
- 11 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 1968-1984
Cross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy
Key Points: The cross-species integration of mouse kidney multi-omics and human genome-wide association study identified 46 cross-species urolithiasis-related molecules. Cell type enrichment suggested that immune cells and collecting duct principal cells may play roles in urolithiasis pathophysiology. Follow-up analyses using human renal data, colocalization, and Mendelian randomization supported the relevance of the detected 46 molecules in humans. Background: Urolithiasis, a recurrent and increasingly prevalent disease worldwide, has a complex pathophysiology that hinders a comprehensive understanding. Methods: We performed a cross-species integrative analysis combining multi-omics profiling of kidneys from a hyperoxaluric mouse model and summary statistics from a large-scale human genome-wide association study (GWAS). Results: In the multi-omics analysis of kidneys from a hyperoxaluric mouse model using RNA-seq, whole-cell proteomics, and phosphoproteomics, we identified 1173 genes, 342 proteins, and 516 phosphorylated peptides that were differentially expressed compared with control mice. We used publicly available large-scale meta-GWAS summary statistics of urolithiasis from BioBank Japan, UK Biobank, and FinnGen ( n =198,769) and prioritized genes using gene enrichment analysis. Through cross-species integration of mouse and human omics, we identified 46 molecules potentially relevant to urolithiasis, hereafter referred to as cross-species urolithiasis-related molecules. We examined the expression and genetic associations of these 46 molecules in human urolithiasis. Among these, CRYAB and SHROOM3 showed differential expression in human renal papilla tissues with and without stones. Colocalization analysis between urolithiasis GWAS and expression quantitative trait loci data of human renal tubules and glomeruli suggested shared signals at the GLUD1 , UMOD , SLC34A1 , TCEA3 , and H1-0 regions. Mendelian randomization analysis using the same renal expression quantitative trait loci datasets further supported these findings, with GLUD1 , UMOD , TCEA3 , and H1-0 showing statistically significant associations, suggesting a strong genetic link with urolithiasis. Conclusions: The study's findings highlight a set of cross-species urolithiasis-related molecules, supported by both expression and genetic evidence, offering insights for future functional validation and mechanistic investigations.
- 11 June 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (9) , 1968-1984
Open AccessCross-Species Comparison between Mouse Kidney Multi-Omics and Human Genome-Wide Association Studies Highlights Molecular Features Associated with Oxalate Nephropathy
Key Points: The cross-species integration of mouse kidney multi-omics and human genome-wide association study identified 46 cross-species urolithiasis-related molecules. Cell type enrichment suggested that immune cells and collecting duct principal cells may play roles in urolithiasis pathophysiology. Follow-up analyses using human renal data, colocalization, and Mendelian randomization supported the relevance of the detected 46 molecules in humans. Background: Urolithiasis, a recurrent and increasingly prevalent disease worldwide, has a complex pathophysiology that hinders a comprehensive understanding. Methods: We performed a cross-species integrative analysis combining multi-omics profiling of kidneys from a hyperoxaluric mouse model and summary statistics from a large-scale human genome-wide association study (GWAS). Results: In the multi-omics analysis of kidneys from a hyperoxaluric mouse model using RNA-seq, whole-cell proteomics, and phosphoproteomics, we identified 1173 genes, 342 proteins, and 516 phosphorylated peptides that were differentially expressed compared with control mice. We used publicly available large-scale meta-GWAS summary statistics of urolithiasis from BioBank Japan, UK Biobank, and FinnGen ( n =198,769) and prioritized genes using gene enrichment analysis. Through cross-species integration of mouse and human omics, we identified 46 molecules potentially relevant to urolithiasis, hereafter referred to as cross-species urolithiasis-related molecules. We examined the expression and genetic associations of these 46 molecules in human urolithiasis. Among these, CRYAB and SHROOM3 showed differential expression in human renal papilla tissues with and without stones. Colocalization analysis between urolithiasis GWAS and expression quantitative trait loci data of human renal tubules and glomeruli suggested shared signals at the GLUD1 , UMOD , SLC34A1 , TCEA3 , and H1-0 regions. Mendelian randomization analysis using the same renal expression quantitative trait loci datasets further supported these findings, with GLUD1 , UMOD , TCEA3 , and H1-0 showing statistically significant associations, suggesting a strong genetic link with urolithiasis. Conclusions: The study's findings highlight a set of cross-species urolithiasis-related molecules, supported by both expression and genetic evidence, offering insights for future functional validation and mechanistic investigations.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Cardiac Sex Disparities are Established Prior to Gonad Formation
Sex disparities in cardiac homeostasis and heart disease are well documented with male-female differences attributed to actions of sex specific hormones. However, recent studies implied sex chromosomes might act outside of the gonads to function in non-hormonal manner. How these two pathways contribute to cardiac sex differences remains unknown. Here, we performed both transcriptional and proteomics profiling to define the molecular differences between male and female mouse hearts. We demonstrate that, contrary to current dogma, cardiac sex disparities are controlled not solely by sex hormones, but also through a sex chromosome mechanism. Using Turner syndrome (XO) and Klinefelter (XXY) mouse models, we find that the sex chromosome pathway is established by X-linked gene dosage. We also show that cardiac sex dipartites occur at the earliest stages of heart formation, a period before gonad formation. These studies provide new insights and resources for studying sex-biased cardiac disease states.
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessCardiac Sex Disparities are Established Prior to Gonad Formation
Sex disparities in cardiac homeostasis and heart disease are well documented with male-female differences attributed to actions of sex specific hormones. However, recent studies implied sex chromosomes might act outside of the gonads to function in non-hormonal manner. How these two pathways contribute to cardiac sex differences remains unknown. Here, we performed both transcriptional and proteomics profiling to define the molecular differences between male and female mouse hearts. We demonstrate that, contrary to current dogma, cardiac sex disparities are controlled not solely by sex hormones, but also through a sex chromosome mechanism. Using Turner syndrome (XO) and Klinefelter (XXY) mouse models, we find that the sex chromosome pathway is established by X-linked gene dosage. We also show that cardiac sex dipartites occur at the earliest stages of heart formation, a period before gonad formation. These studies provide new insights and resources for studying sex-biased cardiac disease states.